Heather DeGrendele

1.8k total citations
17 papers, 1.5k citations indexed

About

Heather DeGrendele is a scholar working on Oncology, Cell Biology and Molecular Biology. According to data from OpenAlex, Heather DeGrendele has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Cell Biology and 5 papers in Molecular Biology. Recurrent topics in Heather DeGrendele's work include Proteoglycans and glycosaminoglycans research (6 papers), Cell Adhesion Molecules Research (5 papers) and Platelet Disorders and Treatments (3 papers). Heather DeGrendele is often cited by papers focused on Proteoglycans and glycosaminoglycans research (6 papers), Cell Adhesion Molecules Research (5 papers) and Platelet Disorders and Treatments (3 papers). Heather DeGrendele collaborates with scholars based in United States and Poland. Heather DeGrendele's co-authors include Pila Estess, Mark Siegelman, Louis J. Picker, Mansour Mohamadzadeh, H. M. Arizpe, Virginia Pascual, Chandra P. Belani, Vinay Jain, Edward Chu and Michael C. Perry and has published in prestigious journals such as Science, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Heather DeGrendele

16 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heather DeGrendele United States 8 824 595 545 483 217 17 1.5k
Staffan Johansson Sweden 23 491 0.6× 727 1.2× 676 1.2× 205 0.4× 78 0.4× 36 1.6k
P W Kincade United States 27 756 0.9× 631 1.1× 1.0k 1.8× 1.5k 3.1× 460 2.1× 40 2.9k
Per Antonsson Sweden 21 606 0.7× 448 0.8× 753 1.4× 307 0.6× 54 0.2× 31 1.9k
G J Dougherty Canada 19 344 0.4× 222 0.4× 741 1.4× 430 0.9× 261 1.2× 36 1.8k
S. Kent Dickeson United States 20 224 0.3× 362 0.6× 385 0.7× 255 0.5× 426 2.0× 37 1.4k
Dorothy W. Kennedy United States 10 597 0.7× 1.1k 1.8× 663 1.2× 133 0.3× 124 0.6× 10 1.6k
Robert Kokenyesi United States 13 1.0k 1.3× 362 0.6× 858 1.6× 99 0.2× 102 0.5× 14 1.6k
Gijs A. van Seventer United States 24 316 0.4× 1.3k 2.1× 594 1.1× 2.0k 4.1× 275 1.3× 37 3.1k
A L Kariniemi Finland 17 291 0.4× 282 0.5× 630 1.2× 288 0.6× 115 0.5× 29 1.6k
J. Middleton United Kingdom 11 186 0.2× 304 0.5× 325 0.6× 487 1.0× 107 0.5× 17 1.2k

Countries citing papers authored by Heather DeGrendele

Since Specialization
Citations

This map shows the geographic impact of Heather DeGrendele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather DeGrendele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather DeGrendele more than expected).

Fields of papers citing papers by Heather DeGrendele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather DeGrendele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather DeGrendele. The network helps show where Heather DeGrendele may publish in the future.

Co-authorship network of co-authors of Heather DeGrendele

This figure shows the co-authorship network connecting the top 25 collaborators of Heather DeGrendele. A scholar is included among the top collaborators of Heather DeGrendele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather DeGrendele. Heather DeGrendele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
DeGrendele, Heather & Vinay Jain. (2003). The Anti-HER2 Monoclonal Antibody Pertuzumab May Be Effective in Androgen-Independent Prostate Cancer. PubMed. 2(3). 143–145. 6 indexed citations
2.
3.
DeGrendele, Heather & Joyce O’Shaughnessy. (2003). A Benefit of Letrozole in Postmenopausal Women After Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer. Clinical Breast Cancer. 4(5). 311–312. 3 indexed citations
4.
DeGrendele, Heather, Chandra P. Belani, & Michael C. Perry. (2003). Epidermal Growth Factor Receptor Inhibitors, Gefitinib and Erlotinib (Tarceva™, OSI-774), in the Treatment of Bronchioloalveolar Carcinoma. Clinical Lung Cancer. 5(2). 83–85. 8 indexed citations
5.
DeGrendele, Heather & Joyce O’Shaughnessy. (2003). Update on High-Dose Adjuvant Chemotherapy and Autologous Stem Cell Rescue in Patients with High-Risk Breast Cancer. Clinical Breast Cancer. 4(3). 173–175. 1 indexed citations
6.
DeGrendele, Heather, Chandra P. Belani, Ralph Naumann, & Charles S. White. (2003). Fluorodeoxyglucose Positron Emission Tomography as a Staging and Prognostic Tool in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 4(4). 213–216. 1 indexed citations
7.
DeGrendele, Heather, Chandra P. Belani, & Harvey I. Pass. (2003). Current Data with Bexarotene (Targretin®) in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 4(4). 210–212. 6 indexed citations
8.
DeGrendele, Heather & Joyce O’Shaughnessy. (2003). Update on the Use of Radiopharmaceuticals for the Treatment of Painful Bone Metastases. Clinical Breast Cancer. 4(4). 248–250. 1 indexed citations
9.
DeGrendele, Heather, Edward Chu, & John L. Marshall. (2003). Activity of the Raf Kinase Inhibitor BAY 43-9006 in Patients with Advanced Solid Tumors. Clinical Colorectal Cancer. 3(1). 16–18. 10 indexed citations
10.
DeGrendele, Heather, et al.. (2002). Highlights from: 38th Annual Meeting of the American Society of Clinical Oncology May 18–21, 2002; Orlando, Florida. Clinical Lymphoma. 3(1). 12–17. 4 indexed citations
11.
DeGrendele, Heather, Chandra P. Belani, & Vinay Jain. (2002). Highlights From: 38th Annual Meeting of the American Society of Clinical Oncology, Orlando, Florida May 18–21, 2002. Clinical Lung Cancer. 4(1). 16–20. 1 indexed citations
12.
Siegelman, Mark, Heather DeGrendele, & Pila Estess. (1999). Activation and interaction of CD44 and hyaluronan in immunological systems. Journal of Leukocyte Biology. 66(2). 315–321. 165 indexed citations
13.
Estess, Pila, Heather DeGrendele, Virginia Pascual, & Mark Siegelman. (1998). Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity.. Journal of Clinical Investigation. 102(6). 1173–1182. 85 indexed citations
14.
Mohamadzadeh, Mansour, Heather DeGrendele, H. M. Arizpe, Pila Estess, & Mark Siegelman. (1998). Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion.. Journal of Clinical Investigation. 101(1). 97–108. 265 indexed citations
15.
DeGrendele, Heather, et al.. (1997). CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. The Journal of Immunology. 159(6). 2549–2553. 142 indexed citations
16.
DeGrendele, Heather, Pila Estess, & Mark Siegelman. (1997). Requirement for CD44 in Activated T Cell Extravasation into an Inflammatory Site. Science. 278(5338). 672–675. 480 indexed citations
17.
DeGrendele, Heather, Pila Estess, Louis J. Picker, & Mark Siegelman. (1996). CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway.. The Journal of Experimental Medicine. 183(3). 1119–1130. 350 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Staffan Johansson Breakdown of academic impact, for papers by P W Kincade Breakdown of academic impact, for papers by Per Antonsson Breakdown of academic impact, for papers by G J Dougherty Breakdown of academic impact, for papers by S. Kent Dickeson Breakdown of academic impact, for papers by Dorothy W. Kennedy Breakdown of academic impact, for papers by Robert Kokenyesi Breakdown of academic impact, for papers by Gijs A. van Seventer Breakdown of academic impact, for papers by A L Kariniemi Breakdown of academic impact, for papers by J. Middleton
Rankless by CCL
2026